Gyros AB licenses patented technology to Fluidigm Corporation
Maris Hartmanis, President and CEO at Gyros AB explained, "We are very pleased that Fluidigm has agreed to become the initial licensee of one of Gyros' early patent filings. We expect that additional companies will also sign up for our licensing program."
Gajus Worthington, President and CEO of Fluidigm added, "this is great technology, and Fluidigm is delighted to have access to it."
Fluidigm has successfully commercialized the Topaz(TM) Crystallizer to automate the metering, mixing, and isolation of protein crystallization experiments. This system is enabled by a proprietary process known as Multi-layer Soft Lithography (MSL(TM)) to manufacture three-dimensional structures from multiple layers of soft elastomer. With this technology, Fluidigm intends to provide an increasing range of products for the biotechnology research market.
Hartmanis continued, "Gyros and Fluidigm are at the forefront in the development of their respective microfluidic technologies. It will be a fascinating journey as we produce more application solutions and see microfluidic-based technologies become standard in the world of drug discovery."
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.